Rilzabrutinib: PDUFA action date for immune thrombocytopenia on Aug 29, 2025 (Sanofi) - Jan 30, 2025 - Q4 & FY2024 Results: Regulatory decisions in EU/China for immune thrombocytopenia in H2 2025
China approval • EMA approval • PDUFA • Immune Thrombocytopenic Purpura • Immunology
|